【结 构 式】 |
【分子编号】13153 【品名】3-(3-bromopropyl) 5-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate 【CA登记号】 |
【 分 子 式 】C19H21BrN2O6 【 分 子 量 】453.28962 【元素组成】C 50.35% H 4.67% Br 17.63% N 6.18% O 21.18% |
合成路线1
该中间体在本合成路线中的序号:(XII)The reaction of diketene (I) with 2-bromoethanol (II) by means of dimethylaminopyridine (DMAP) in dichloromethane gives acetoacetic acid 2-bromoethyl ester (III), which is condensed with 3-nitrobenzaldehyde (IV) by means of piperidine acetate in isopropanol yielding the corresponding 3-nitrobenzylidene derivative (V). The cyclization of (V) with methyl 3-aminocrotonate (VI) by heating at 80 C affords 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-bromoethyl) 5-methyl diester (VII), which is condensed with chloromethyl ethyl ether (VIII) by means of NaH in THF to afford the corresponding 1-ethoxymethyl derivative (IX). The reaction of diester (IX) with NaCN and tetrabutylammonium cyanide or sodium p-toluenesulfonate and benzyltriethylammonium chloride (BTEACl) in DMF gives 1-(ethoxymethyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid monomethyl ester (X). The optical resolution of (X) through the cinchonidine salt yields, after crystallization, the cinchonidine salt of the (R)-enantiomer (XI), which is treated with HCl to eliminate the cinchonidine, and esterified with 1,3-dibromopropane and K2CO3 in acetone to afford (R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(3-bromopropyl) 5-methyl diester (XII). Finally, this compound is condensed with 4,4-diphenylpiperidine (XIII) by means of K2CO3 in DMF at 100 C.
【1】 Robinson, K.A.; Robinson, C.P.; Castaner, J.; Dexniguldipine hydrochloride. Drugs Fut 1997, 22, 2, 114. |
【2】 Amschler, H.; Flockerzi, D.; Klemm, K.; Kohl, B.; Eistetter, K.; Eltze, M.; Kolassa, N.; Sanders, K.; Schudt, C. (Byk Gulden Lomberg Chemische Fabrik GmbH); 1,4-Dihydropyridine enantiomers. AU 8816264; EP 0296316; EP 0343193; WO 8807525 . |
【3】 Klemm, K.; Ulrich, W.-R.; Flockerzi, D.; Sanders, K.; Beller, K.-D. (Byk Gulden Lomberg Chemische Fabrik GmbH); Optically pure (R)-(-)-niguldipine and its derivs. for treating tumor diseases. WO 8907443 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11367 | 4-Methylene-2-oxetanone; Acetyl ketene | 674-82-8 | C4H4O2 | 详情 | 详情 |
(II) | 10059 | Ethylene bromohydrin; 2-Bromo-1-ethanol | 540-51-2 | C2H5BrO | 详情 | 详情 |
(III) | 13144 | 2-bromoethyl 3-oxobutanoate | C6H9BrO3 | 详情 | 详情 | |
(IV) | 12646 | 3-Nitrobenzaldehyde | 99-61-6 | C7H5NO3 | 详情 | 详情 |
(V) | 13146 | 2-bromoethyl (Z)-2-acetyl-3-(3-nitrophenyl)-2-propenoate | C13H12BrNO5 | 详情 | 详情 | |
(VI) | 11372 | Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate | C5H9NO2 | 详情 | 详情 | |
(VII) | 63539 | 3-(2-bromoethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate | C18H19BrN2O6 | 详情 | 详情 | |
(VIII) | 13149 | 1-(Chloromethoxy)ethane; Chloromethyl ethyl ether | 3188-13-4 | C3H7ClO | 详情 | 详情 |
(IX) | 13150 | 3-(2-bromoethyl) 5-methyl 1-(ethoxymethyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate | C21H25BrN2O7 | 详情 | 详情 | |
(X) | 13151 | 1-(Ethoxymethyl)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylic acid | C19H22N2O7 | 详情 | 详情 | |
(XI) | 12671 | (4S)-1-(Ethoxymethyl)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylic acid | C19H22N2O7 | 详情 | 详情 | |
(XII) | 13153 | 3-(3-bromopropyl) 5-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate | C19H21BrN2O6 | 详情 | 详情 | |
(XIII) | 13154 | 4,4-Diphenylpiperidine | C17H19N | 详情 | 详情 |